Blanka Pranjic joined MC Toxicology Consulting in March 2017. She has been involved in the preparation of different regulatory documents required during drug development. Blanka studied molecular biology at the University of Zagreb and completed her doctoral theses at the Institute of Molecular Biotechnology (IMBA) in Vienna. During her doctoral and postdoctoral training, she gained broad expertise in the fields of genetics and cancer research.

 Toxicology, Pharmacology, and Pharmacokinetics